Best Practice Recommendations for Canadian Harm Reduction Programs
Drug use practices that can lead to transmission of HIV, HCV, and other infections are pressing issues affecting communities throughout Canada. To stay current with emerging evidence and ensure that people have access to high-quality services that help prevent HIV and HCV transmission, best practice recommendations must undergo review and update. A Canada-wide team of researchers, service providers, policy makers and people with lived experience have developed, through extensive literature review and synthesis, an updated and comprehensive set of best practice recommendations.
This document has new and improved best practice recommendations about needle and syringe distribution, other injection equipment distribution, handling and disposal of used drug-use equipment, and safer drug-use education. In addition, lots of new material can be found on safer crack cocaine smoking equipment distribution and opioid overdose prevention (education and naloxone distribution). Below are links to the full set of recommendations, individual recommendations for equipment, disposal and education, and informative one-pager summaries of the recommendations and evidence:
Best Practice Recommendations for Canadian Harm Reduction Programs that Provide Service to People Who Use Drugs and are at Risk for HIV, HCV, and Other Harms: Part 1
Part 1 Summaries
- Alcohol swab distribution
- Ascorbic acid distribution
- Cooker distribution (updated version)
- Disposal and handling of used drug equipment
- Filter distribution
- Needle and syringe distribution
- Opioid overdose prevention: education and naloxone distribution (updated version)
- Safer crack cocaine smoking equipment distribution
- Safer drug use education
- Sterile water distribution
- Tourniquet distribution
CATIE Webinar: New recommendations for the delivery of harm reduction programming in Canada Part 1
Wednesday, November 27, 2013
This webinar helps service providers and community members become familiar with the newest practice recommendations for Canadian harm reduction programs that serve people who use drugs and are at risk for HIV, HCV and other harms.
Who is this webinar for?
This webinar is for service providers, community members and policy makers who would like to become familiar with the newest best practice recommendations for Canadian harm reduction programs that serve people who use drugs and are at risk for HIV, HCV and other harms.
- Best Practice Recommendations for Canadian Harm Reduction Programs that Provide Service to People Who Use Drugs and are at Risk for HIV, HCV, and Other Harms: Part 2
Part 2 Summaries
- Program delivery models (includes fixed-site NSPs, mobile NSPs, pharmacy-based distribution and purchase, peer-based outreach, and needle/syringe vending machines)
- Needle distribution for anabolic steroid injection, hormone injection, piercing and/or tattooing
- Foil distribution
- Safer crystal methamphetamine smoking equipment distribution
- Injection-related complications –prevention, assessment and treatment
- Testing services for HIV, hepatitis C, hepatitis B, and tuberculosis
- Vaccination services for hepatitis A and B, pneumococcal pneumonia, influenza, tetanus, and diphtheria
- HIV and/or hepatitis C treatment referrals
- Substance use treatment referrals
- Mental health services referrals
- Housing services referrals
- Relationships with law enforcement
- Education and other services for the prison context
CATIE Webinar: New recommendations for the delivery of harm reduction programming in Canada Part 2
This webinar introduces recommendations included in Part 2 of the Best Practice Recommendations for Canadian Harm Reduction Programs. Developed by service providers, service users and researchers from across Canada, the second instalment of the recommendations focuses on service models, referrals to services and emerging areas of practice.